Related references
Note: Only part of the references are listed.Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
Alan D. Michelson et al.
EUROPEAN HEART JOURNAL (2009)
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid Determinants and Effect on Cardiovascular Risk
John W. Eikelboom et al.
CIRCULATION (2008)
Use of the PFA-100 (TM) closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis
J.-L. Reny et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy
Douglas J. Christie et al.
PLATELETS (2008)
Rebuttal to Aspirin response variability assessed with the PFA-100 device by Reny et al.
Marilena Crescente et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis
George Krasopoulos et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events - A systematic review and meta-analysis
Jaapjan D. Snoep et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Aspirin dose for the prevention of cardiovascular disease - A systematic review
Charles L. Campbell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Indices of platelet activation and the stability of coronary artery disease
M. D. Linden et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Marcel M. C. Hovens et al.
AMERICAN HEART JOURNAL (2007)
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention - Insights into the STRATEGY study
Gianluca Campo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
I. Fuchs et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events
Burak Pamukcu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway - A 700-patient study of aspirin resistance
Andrew L. Frelinger et al.
CIRCULATION (2006)
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
T. Ohmori et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers
P Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: A 6 months prospective study
Jacopo Gianetti et al.
THROMBOSIS RESEARCH (2006)
Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation
US Tantry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Aspirin resistance: Position paper of the working group on aspirin resistance
AD Michelson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
Catharina Borna et al.
THROMBOSIS JOURNAL (2005)
Expert consensus document on the use of antiplatelet agents - The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology
C Patrono et al.
EUROPEAN HEART JOURNAL (2004)
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes - Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
RJG Peters et al.
CIRCULATION (2003)
Aspirin resistance: definition, mechanisms and clinical read-outs
C Patrono
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease
EJ Topol et al.
CIRCULATION (2003)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom et al.
CIRCULATION (2002)
The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making
EM Antman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Evaluation of platelet function by flow cytometry
AD Michelson et al.
METHODS (2000)
Share Paper
